CANC ETF
Tema Oncology ETF
CANC ETF Overview
CANC ETF (Tema Oncology ETF) is managed by Tema Global Limited with $208.8M in net assets. CANC expense ratio is 0.75%, holding 118 positions across sectors including Health Care, Financials. Inception date: 2023-08-15.
CANC performance shows a YTD return of 25.29%. The 1-year return is 62.87%. CANC dividend yield stands at 0.05%, paid annually.
CANC top holdings include Revolution Medicines Inc (5.5%), Cogent Biosciences Inc (5.0%), Merck & Company Inc (4.7%), Eli Lilly & Co. (4.5%), Novartis Ag - Common (3.6%). Go to all CANC holdings, CANC sectors, or CANC dividends.
CANC can be compared against other funds. Use CANC overlap to find shared positions, or CANC vs another fund for a side-by-side view. CANC alternatives are available via the screener, along with tax-loss harvesting opportunities.